The forecast for systemic hormonal preparations sales (excluding sex hormones and insulins) in the UK shows a slight decline over the period from 2024 to 2028. In 2023, the actual sales value was higher, indicating a downward trend starting in 2024. The year-on-year variation indicates a 4.35% decrease from 2024 to 2025, with stability from 2025 to 2027, and a further 4.55% drop by 2028. The compound annual growth rate (CAGR) over the five-year forecast period suggests a subtle average decline per year.

Future trends to watch for include:

Potential new healthcare policies influencing drug prescriptions.
Introduction or expansion of alternative therapies affecting traditional hormonal preparation usage.
Advancements in precision medicine that may customize hormonal treatments.
Demographic changes like aging populations potentially impacting demand.